Table 2 Indications and type of treatment of patients treated with chronic anticoagulant drugs (n = 84).
INR at admission | 2.12 (1.68–2.70) |
2<INR<3 (therapeutic range) | 44 (52%) |
Indication | |
Valve disease | 2 (2%) |
Atrial fibrillation | 32 (38%) |
Valve disease and atrial fibrillation | 7 (8%) |
Pulmonary embolism, venous thrombosis, or both | 21 (25%) |
Thrombophilia (factor V Leiden mutation) | 2 (2%) |
Altered LVEF (<35%) | 10 (12%) |
Others or unknown | 8 (10%) |
Drug | |
Warfarin | 2 (2%) |
Fluindione | 63 (73%) |
Acenocoumarol | 13 (15%) |
Data are number (%) or median (interquartile range).
INR, international normalised ratio; LVEF, left ventricular ejection fraction.